ATAI

ATAI Life Sciences NV (ATAI)

ATAI Life Sciences NV

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ATAI

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/03/06	06 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATAI	ATAI Life Sciences NV
2025/03/05	21 : 00	GlobeNewswire Inc.	atai Life Sciences Announces Completion of Enrollment in Phase 2b Clinical Trial Evaluating BPL-003 for Treatment-Resistant Depression	NASDAQ:ATAI	ATAI Life Sciences NV
2025/02/25	11 : 59	Edgar (US Regulatory)	Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership	NASDAQ:ATAI	ATAI Life Sciences NV
2025/02/25	06 : 10	GlobeNewswire Inc.	atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference	NASDAQ:ATAI	ATAI Life Sciences NV
2025/02/20	21 : 00	GlobeNewswire Inc.	atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares	NASDAQ:ATAI	ATAI Life Sciences NV
2025/02/20	08 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATAI	ATAI Life Sciences NV
2025/02/14	06 : 37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATAI	ATAI Life Sciences NV
2025/02/14	06 : 35	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ATAI	ATAI Life Sciences NV
2025/02/13	12 : 47	GlobeNewswire Inc.	atai Life Sciences Announces Pricing of Public Offering of Common Shares	NASDAQ:ATAI	ATAI Life Sciences NV
2025/02/13	06 : 16	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ATAI	ATAI Life Sciences NV
2025/02/13	06 : 01	GlobeNewswire Inc.	atai Life Sciences Announces Proposed Public Offering of Common Shares	NASDAQ:ATAI	ATAI Life Sciences NV
2025/01/28	21 : 00	GlobeNewswire Inc.	atai Life Sciences Announces Positive Topline Results from Beckley Psytech’s BPL-003 (intranasal 5-MeO-DMT benzoate) Phase 2a Open-Label Study for Alcohol Use Disorder	NASDAQ:ATAI	ATAI Life Sciences NV
2025/01/25	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATAI	ATAI Life Sciences NV
2025/01/11	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATAI	ATAI Life Sciences NV
2025/01/11	06 : 15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ATAI	ATAI Life Sciences NV
2025/01/11	06 : 15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ATAI	ATAI Life Sciences NV
2025/01/10	21 : 23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATAI	ATAI Life Sciences NV
2025/01/10	21 : 00	GlobeNewswire Inc.	atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health	NASDAQ:ATAI	ATAI Life Sciences NV
2024/12/14	06 : 15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ATAI	ATAI Life Sciences NV
2024/11/13	22 : 19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATAI	ATAI Life Sciences NV
2024/11/13	22 : 00	GlobeNewswire Inc.	atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates	NASDAQ:ATAI	ATAI Life Sciences NV
2024/11/11	21 : 30	GlobeNewswire Inc.	Altimmune Appoints Life Sciences Industry Veteran Greg Weaver as Chief Financial Officer	NASDAQ:ATAI	ATAI Life Sciences NV
2024/10/15	21 : 00	GlobeNewswire Inc.	atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit	NASDAQ:ATAI	ATAI Life Sciences NV
2024/10/05	05 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATAI	ATAI Life Sciences NV
2024/10/05	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATAI	ATAI Life Sciences NV
2024/10/05	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATAI	ATAI Life Sciences NV
2024/10/05	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATAI	ATAI Life Sciences NV
2024/10/05	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATAI	ATAI Life Sciences NV
2024/09/04	20 : 00	GlobeNewswire Inc.	atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:ATAI	ATAI Life Sciences NV
2024/08/14	20 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATAI	ATAI Life Sciences NV